Cargando…

Hepatocellular carcinoma progression during bridging before liver transplantation

BACKGROUND: Recipient selection for liver transplantation in hepatocellular carcinoma (HCC) is based primarily on criteria affecting the chance of long-term success. Here, the relationship between pretransplant bridging therapy and long-term survival was investigated in a subgroup analysis of the Si...

Descripción completa

Detalles Bibliográficos
Autores principales:	Renner, P, Da Silva, T, Schnitzbauer, A A, Verloh, N, Schlitt, H J, Geissler, E K
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8038254/ https://www.ncbi.nlm.nih.gov/pubmed/33839747 http://dx.doi.org/10.1093/bjsopen/zrab005

Ejemplares similares

Liver transplantation as curative approach for advanced hepatocellular carcinoma: is it justified?
por: Obed, Aiman, et al.
Publicado: (2007)

Bridging therapies to liver transplantation for hepatocellular carcinoma: A bridge to nowhere?
por: Tan, Chun Han Nigel, et al.
Publicado: (2018)

Transarterial Embolization and Percutaneous Ethanol Injection as an Effective Bridge Therapy before Liver Transplantation for Hepatitis C-Related Hepatocellular Carcinoma
por: Chedid, Marcio F., et al.
Publicado: (2016)

Study Protocol: A Pilot Study to Determine the Safety and Efficacy of Induction-Therapy, De Novo MPA and Delayed mTOR-Inhibition in Liver Transplant Recipients with Impaired Renal Function. PATRON-Study
por: Schnitzbauer, Andreas A, et al.
Publicado: (2010)

Bridging treatment prior to liver transplantation for hepatocellular carcinoma: radioembolization or transarterial chemoembolization?
por: Benkö, Tamás, et al.
Publicado: (2022)

Biliary Leak after Pediatric Liver Transplantation Treated by Percutaneous Transhepatic Biliary Drainage—A Case Series
por: Doppler, Michael, et al.
Publicado: (2023)

Liver Transplantation for Hepatocellular Carcinoma after Downstaging or Bridging Therapy with Immune Checkpoint Inhibitors
por: Gao, Qimeng, et al.
Publicado: (2021)

Safety and feasibility of third-party multipotent adult progenitor cells for immunomodulation therapy after liver transplantation--a phase I study (MISOT-I)
por: Popp, Felix C, et al.
Publicado: (2011)

Multimodality locoregional treatment strategies for bridging HCC patients before liver transplantation
por: Györi, Georg P., et al.
Publicado: (2017)

European Society of Organ Transplantation (ESOT) Consensus Report on Downstaging, Bridging and Immunotherapy in Liver Transplantation for Hepatocellular Carcinoma
por: Claasen, Marco Petrus Adrianus Wilhelmus, et al.
Publicado: (2023)

Transcatheter Arterial Chemoembolization of Hepatocellular Carcinoma as a Bridge to Liver Transplantation: A Retrospective Study
por: Bouchard-Fortier, Antoine, et al.
Publicado: (2011)

Stereotactic Body Radiation Therapy as a Bridge to Transplantation and for Recurrent Disease in the Transplanted Liver of a Patient with Hepatocellular Carcinoma
por: Mazloom, Ali, et al.
Publicado: (2014)

A prospective clinical trial on sorafenib treatment of hepatocellular carcinoma before liver transplantation
por: Eilard, Malin Sternby, et al.
Publicado: (2019)

Outcomes After Stereotactic Body Radiation Therapy as a Bridging Modality to Liver Transplantation for Hepatocellular Carcinoma
por: Garg, Rashi, et al.
Publicado: (2020)

PD-1 expression in hepatocellular carcinoma predicts liver-directed therapy response and bridge-to-transplant survival
por: Núñez, Kelley G., et al.
Publicado: (2021)

Bridging and downstaging with TACE in early and intermediate stage hepatocellular carcinoma: Predictors of receiving a liver transplant
por: Yin, Chao, et al.
Publicado: (2022)

Long-Term Outcome After Liver Transplantation for Hepatocellular Carcinoma Following Yttrium-90 Radioembolization Bridging Treatment
por: Radunz, Sonia, et al.
Publicado: (2017)

Liver Transplantation for Hepatocellular Carcinoma
por: Mazzaferro, Vincenzo, et al.
Publicado: (2008)

Liver Transplantation as a Cornerstone Treatment for Acute-On-Chronic Liver Failure
por: Schulz, Martin S., et al.
Publicado: (2022)

Hypoalbuminemia Is a Hepatocellular Carcinoma Independent Risk Factor for Tumor Progression in Low-Risk Bridge to Transplant Candidates
por: Núñez, Kelley G., et al.
Publicado: (2022)

Bridging and downstaging role of trans-arterial radio-embolization for expected small remnant volume before liver resection for hepatocellular carcinoma
por: Shehta, Ahmed, et al.
Publicado: (2020)

mTOR inhibition improves fibroblast growth factor receptor targeting in hepatocellular carcinoma
por: Scheller, T, et al.
Publicado: (2015)

Sirolimus Use in Liver Transplant Recipients With Hepatocellular Carcinoma: A Randomized, Multicenter, Open-Label Phase 3 Trial
por: Geissler, Edward K., et al.
Publicado: (2016)

Immune microenvironment and therapeutic progress of recurrent hepatocellular carcinoma after liver transplantation
por: Jin, Xin, et al.
Publicado: (2022)

Liver transplantation for advanced hepatocellular carcinoma
por: Lee, Hae Won, et al.
Publicado: (2016)

Extremes of Liver Transplantation for Hepatocellular Carcinoma
por: Grąt, Michał, et al.
Publicado: (2019)

Histological Correlation for Radiofrequency and Microwave Ablation in the Local Control of Hepatocellular Carcinoma (HCC) before Liver Transplantation: A Comprehensive Review
por: Habibollahi, Peiman, et al.
Publicado: (2020)

Corrigendum: Bridging and downstaging role of trans-arterial radio-embolization for expected small remnant volume before liver resection for hepatocellular carcinoma
por: Shehta, Ahmed, et al.
Publicado: (2021)

Clinical, Epidemiological and Histopathological Aspects in Patients with Hepatocellular Carcinoma Undergoing Liver Transplantation
por: Tunissiolli, Nathalia Martines, et al.
Publicado: (2018)

Liver Transplantation for Alcoholic Liver Disease and Hepatocellular Carcinoma
por: Burra, Patrizia, et al.
Publicado: (2018)

Steatotic Livers Are More Susceptible to Ischemia Reperfusion Damage after Transplantation and Show Increased γδ T Cell Infiltration
por: Eggenhofer, Elke, et al.
Publicado: (2021)

Stereotactic body radiation therapy (SBRT) for definitive treatment and as a bridge to liver transplantation in early stage inoperable Hepatocellular carcinoma
por: Moore, Assaf, et al.
Publicado: (2017)

Impact of successful local ablative bridging therapy prior to liver transplantation on long-term survival in patients with hepatocellular carcinoma in cirrhosis
por: Bauschke, Astrid, et al.
Publicado: (2020)

Hepatocellular Carcinoma and Liver Transplantation: State of the Art
por: Mancuso, Andrea, et al.
Publicado: (2014)

Thrombosis after liver transplantation for hepatocellular carcinoma
por: Martinelli, Ida, et al.
Publicado: (2017)

The Role of Bridging Therapy in Hepatocellular Carcinoma
por: Galuppo, Roberto, et al.
Publicado: (2013)

Salvage Liver Transplant versus Primary Liver Transplant for Patients with Hepatocellular Carcinoma
por: Yadav, Dipesh Kumar, et al.
Publicado: (2018)

Liver Transplantation for Hepatocellular Carcinoma among African Americans in the United States
por: Sourianarayanane, A., et al.
Publicado: (2012)

Liver transplantation for hepatocellular carcinoma: Historical evolution of transplantation criteria
por: Ince, Volkan, et al.
Publicado: (2022)

High normal values of circulating immune cell subsets before surgery may be protective against development of postoperative acute kidney injury
por: Ehehalt, K, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_jakh6fkukl8sshfblv0uucf0gi